ELVN Competitors & Alternatives

Compare Enliven Therapeutics Inc. with similar stocks in the same industry

Biotechnology

ELVN

Main Stock
$47.54
-2.58%
Tradestie Score
34
Market Cap
$1.17B
Analyst Upside
+56.4%

Top Competitors

214 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ZLAB Zai Lab Limited American Depositary Shares
$23.74
-3.50%
$3.83B - 44 Compare
AAPG Ascentage Pharma Group International American Depository Shares
$13.43
-8.14%
$3.68B - 51 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$92.92
-1.14%
$3.67B - 38 Compare
ADMA ADMA Biologics, Inc.
$13.70
+0.11%
$3.59B 17.2 28 Compare
ACAD Acadia Pharmaceuticals Inc.
$19.07
+1.71%
$3.58B 8.6 47 Compare
LGND Ligand Pharmaceuticals Inc.
$304.93
-1.25%
$3.49B 127.0 45 Compare
TLX Telix Pharmaceuticals Limited American Depositary Shares
$8.99
-2.65%
$3.40B 93.6 58 Compare
QURE uniQure N.V.
$22.02
-7.52%
$3.39B - 51 Compare
SRRK Scholar Rock Holding Corporation Common Stock
$43.21
+0.01%
$3.33B - 56 Compare
NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares
$19.76
-1.89%
$3.31B - 49 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

214 stocks in this industry